Table 2. Univariate and multivariate analysis of prognostic variables in EGAC.
| Variable | Univariate analysis | Multivariate analysis | |||||
|---|---|---|---|---|---|---|---|
| P value | HR | 95% CI | P value | HR | 95% CI | ||
| GPC1 expression (low/high) | 0.005* | 1.491 | 1.126–2.046 | 0.024* | 1.392 | 1.041–2.011 | |
| TNM stage (I + II/III + IV) | <0.001 | 2.394 | 1.811–3.345 | 0.185 | 1.482 | 0.835–2.256 | |
| T stage (T1 + T2/T3 + T4) | <0.005* | 2.129 | 1.243–3.554 | 0.04* | 1.68 | 1.002–2.650 | |
| N stage (N0/N1 + N2 + N3) | <0.001* | 2.509 | 1.873–3.270 | 0.001* | 1.909 | 1.290–2.799 | |
| Age (<60/>60) | 0.646 | 1.045 | 0.786–1.478 | – | – | – | |
| Sex (male/female) | 0.716 | 1.066 | 0.810–1.430 | – | – | – | |
*, P<0.05. EGAC, esophagogastric cancer; HR, hazard ratio; CI, confidence interval; GPC1, glypican 1. TNM, tumour, node and metastasis.